Medexus Pharmaceuticals (TSX:MDP) Operating Cash Flow per Share : C$1.31 (TTM As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Medexus Pharmaceuticals Operating Cash Flow per Share?

Medexus Pharmaceuticals's operating cash flow per share for the three months ended in Dec. 2023 was C$0.31. Medexus Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$1.31.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 17.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Medexus Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

TSX:MDP' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 7.6 Med: 17 Max: 57.5
Current: 17

During the past 12 years, Medexus Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 57.50% per year. The lowest was 7.60% per year. And the median was 17.00% per year.

TSX:MDP's 3-Year OCF Growth Rate is ranked better than
62.76% of 803 companies
in the Drug Manufacturers industry
Industry Median: 7 vs TSX:MDP: 17.00

Medexus Pharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Medexus Pharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Operating Cash Flow per Share Chart

Medexus Pharmaceuticals Annual Data

Trend

Dec13

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.10

-0.17

0.42

-0.08

-0.10

Medexus Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.15	0.24	0.28	0.49	0.31

Competitive Comparison of Medexus Pharmaceuticals's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Medexus Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medexus Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medexus Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medexus Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Medexus Pharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Medexus Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	-1.976	/	20.524
	=	-0.10

Medexus Pharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	7.434	/	24.183
	=	0.31

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.31

Medexus Pharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals (TSX:MDP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

MEDXF:USA P731:Germany

Address

35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1

Website

https://www.medexus.com

Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.

Executives

Benoit Gravel

Director